A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis.

被引：0
|
作者：
Chakravarty, Eliza F. [1 ]
Fiorentino, David
Bennett, Mihoko
Chung, Lorinda [2 ]
机构：
[1] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
707
引用
收藏
页码：S274 / S275
页数：2
相关论文
共 50 条
  • [41] Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
    Eliza F. Chakravarty
    Viktor Martyanov
    David Fiorentino
    Tammara A. Wood
    David James Haddon
    Justin Ansel Jarrell
    Paul J. Utz
    Mark C. Genovese
    Michael L. Whitfield
    Lorinda Chung
    Arthritis Research & Therapy, 17
  • [42] Microchimerism in Japanese patients with systemic sclerosis.
    Murata, H
    Sumida, T
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S204 - S204
  • [43] Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
    Spierings, Julia
    Nienhuis, Hilde
    van Lieshout, Eva
    van Laar, Jacob M.
    Pieterse, Arwen H.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (01) : 42 - 48
  • [44] Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
    Herrick, Ariane L.
    Pan, Xiaoyan
    Peytrignet, Sebastien
    Lunt, Mark
    Hesselstrand, Roger
    Mouthon, Luc
    Silman, Alan
    Brown, Edith
    Czirjak, Laszlo
    Distler, Joerg H. W.
    Distler, Oliver
    Fligelstone, Kim
    Gregory, William J.
    Ochiel, Rachel
    Vonk, Madelon
    Ancuta, Codrina
    Ong, Voon H.
    Farge, Dominique
    Hudson, Marie
    Matucci-Cerinic, Marco
    Balbir-Gurman, Alexandra
    Midtvedt, Oyvind
    Jordan, Alison C.
    Jobanputra, Paresh
    Stevens, Wendy
    Moinzadeh, Pia
    Hall, Frances C.
    Agard, Christian
    Anderson, Marina E.
    Diot, Elisabeth
    Madhok, Rajan
    Akil, Mohammed
    Buch, Maya H.
    Chung, Lorinda
    Damjanov, Nemanja
    Gunawardena, Harsha
    Lanyon, Peter
    Ahmad, Yasmeen
    Chakravarty, Kuntal
    Jacobsen, Soren
    MacGregor, Alexander J.
    McHugh, Neil
    Mueller-Ladner, Ulf
    Riemekasten, Gabriela
    Becker, Michael
    Roddy, Janet
    Carreira, Patricia E.
    Fauchais, Anne Laure
    Hachulla, Eric
    Hamilton, Jennifer
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1207 - 1218
  • [45] INFORMATION PREFERENCES ABOUT TREATMENT OPTIONS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A DELPHI CONSENSUS STUDY
    Spierings, J.
    Nienhuis, H.
    Van Lieshout, E.
    Van Laar, J. M.
    Pieterse, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1478 - 1479
  • [46] Metoclopramide response in patients with early diffuse systemic sclerosis.: Effects on esophageal motility abnormalities
    Mercado, U
    de Anda, RA
    Avendaño, L
    Araiza-Casillas, R
    Avendaño-Reyes, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (05) : 685 - 688
  • [47] Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis
    Ostojic, Predrag
    Damjanov, Nemanja
    CLINICAL RHEUMATOLOGY, 2006, 25 (04) : 453 - 457
  • [48] Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis
    Predrag Ostojić
    Nemanja Damjanov
    Clinical Rheumatology, 2006, 25 : 453 - 457
  • [49] B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic Sclerosis
    Lafyatis, Robert
    Kissin, Eugene
    York, Michael
    Farina, Giuseppina
    Viger, Kerry
    Fritzler, Marvin J.
    Merkel, Peter A.
    Simms, Robert W.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (02): : 578 - 583
  • [50] Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
    Hasegawa, Minoru
    Fujimoto, Manabu
    Matsushita, Takashi
    Hamaguchi, Yasuhito
    Takehara, Kazuhiko
    RHEUMATOLOGY, 2013, 52 (02) : 242 - 251
12345